
Kuros Biosciences AG
SIX:KURN.SW
Overview | Financials
Company Name | Kuros Biosciences AG |
Symbol | KURN.SW |
Currency | CHF |
Price | 19.9 |
Market Cap | 755,411,960 |
Dividend Yield | 0% |
52-week-range | 4.7 - 32 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Joost D. de Bruijn B.Sc. Ph.D., Ph.D. |
Website | https://www.kuros.ch |
An error occurred while fetching data.
About Kuros Biosciences AG
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD